Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients
CONVINT
Prospective Randomised Clinical Trial of the Effect of Continuous Versus Intermittent Renal Replacement Therapy on the Mortality and Outcome of Acute Renal Failure in ICU Patients
1 other identifier
interventional
252
1 country
1
Brief Summary
The mortality of acute renal failure (ARF) remains to be high (around 60-70%) despite manifold improvements in ICU care. At present, it is not clear if the method chosen for renal replacement therapy, i.e. intermittent haemodialysis (IHD) or continuous haemofiltration (CVVH), might impact on the outcome of these patients. For this purpose, a prospective randomised clinical study of the effect of continuous versus intermittent renal replacement therapy on the mortality and outcome of acute renal failure will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jan 2002
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 25, 2010
CompletedFirst Posted
Study publicly available on registry
October 26, 2010
CompletedMay 25, 2011
July 1, 2010
5.8 years
October 25, 2010
May 23, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Survival at 2 weeks after RRT
2 weeks after RRT in follow-up
Study Arms (2)
CVVH arm
ACTIVE COMPARATORIHD arm
ACTIVE COMPARATORInterventions
patients randomized to receive CVVH
patients randomized to receive IHD
Eligibility Criteria
You may qualify if:
- all ICU patients requiring renal replacement therapy
You may not qualify if:
- patient denies informed consent
- patient not requiring intensive care therapy
- kidney transplanted patients
- chronic renal failure (serum creatinine \> 3mg/dl)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charite University Medicine
Berlin, State of Berlin, 13353, Germany
Related Publications (2)
Tsujimoto Y, Miki S, Shimada H, Tsujimoto H, Yasuda H, Kataoka Y, Fujii T. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
PMID: 34519356DERIVEDSchefold JC, von Haehling S, Pschowski R, Bender T, Berkmann C, Briegel S, Hasper D, Jorres A. The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care. 2014 Jan 10;18(1):R11. doi: 10.1186/cc13188.
PMID: 24405734DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Achim Joerres, MD
Charite University Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 25, 2010
First Posted
October 26, 2010
Study Start
January 1, 2002
Primary Completion
October 1, 2007
Study Completion
January 1, 2008
Last Updated
May 25, 2011
Record last verified: 2010-07